RXRX logo

Combined Holdings of RXRX in All ARK ETFs

Recursion Pharmaceuticals

Recursion Pharmaceuticals operates as a biotechnology company that leverages machine learning and automation to discover new drugs and advance them through the drug development pipeline more efficiently. The company generates revenue primarily through partnerships and collaborations with other pharmaceutical firms, leveraging its proprietary technology and expertise to aid in drug discovery and development efforts.

Trades of RXRX in All Ark ETFs

The ten most recent trades of Recursion Pharmaceuticals in all the Ark ETFs ETF.View all trades

Date
Direction
Market Value
% of Position
% of ETF
Jan 10, 2025Buy$1,832,9891.42%0.03%
Jan 08, 2025Buy$4,698,9903.64%0.07%
Jan 03, 2025Buy$336,6530.39%0.03%
Nov 25, 2024Buy$595,8960.84%0.05%
Nov 20, 2024Buy$1,963,6141.85%0.03%
Nov 20, 2024Buy$349,5470.50%0.03%
Nov 15, 2024Buy$1,940,7191.72%0.03%
Nov 06, 2024Buy$127,1300.16%0.01%
Nov 04, 2024Buy$683,3710.62%0.01%
Nov 01, 2024Buy$103,7460.09%0.00%